We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we ...

Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz Jared Holz, Mizuho, ...

Attorney General Keith Ellison reached a settlement with insulin manufacturers Eli Lilly, Sanofi, and Novo Nordisk, which ...

Eli Lilly (NYSE: LLY) began a roll in late 2020 that lasted almost four years. This decline includes a sell-off earlier this week after Lilly cut its 2024 revenue guidance due to lower-than-expected ...

In the final years of her husband's life, BJ Carter finally learned details of her husband's life he'd never remembered.

Such price increases could directly benefit Eli Lilly by boosting sales of its diabetes ... Trump referred to himself as "Tariff Man" during the campaign. He wants tariffs of at least 10% and ...

Eli Lilly (NYSE: LLY) began a roll in late 2020 ... Trump referred to himself as "Tariff Man" during the campaign. He wants tariffs of at least 10% and up to 20% on all imports.

Highlights,Institutional holdings in Eli Lilly (NYSE:LLY) continue to expand, with significant new positions added.,Geode ...

Highlights,SkyOak Wealth LLC adjusted its stake in Eli Lilly (NYSE:LLY) in the fourth quarter, reducing its position by a ...

U.S. stock futures point higher ahead of closely watched CPI report, JPMorgan Chase stock rises on better-than-expected results, and economists expect annual inflation to have risen in December.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?